Triamcinolone Acetonide NDC 46287-010

NDC codes

FDA NDC Directory

Product NDC (as listed)46287-010Labeler and product segments. Claims need a package NDC.

Product NDC at billing width46287-0010Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
46287-010-11	46287001011	110 g in 1 JAR (46287-010-11)Marketed from Aug 23, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamcinolone Acetonide
Generic name (nonproprietary): triamcinolone acetonide
Active ingredients: Triamcinolone acetonide — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: CMP Pharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 089595
Marketing start: Aug 23, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 46287-010_647c8a0c-803a-4efb-9c31-1269512aa1f9SPL ID 647c8a0c-803a-4efb-9c31-1269512aa1f9SPL set ID 5067e7da-3eed-4d6a-b870-47a35c3ded81RxCUI 1090641UNII F446C597KAUPC 0346287010111
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N446287001011 followed by a unit qualifier and the quantity

Package 46287-0010-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 17, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Triamcinolone Acetonide 0.05% in Absorbase ® (Triamcinolone Acetonide Ointment, USP) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)